Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.51−0.02 (-1.31%)
Close on Nov 13, 2026Market cap $850.64KP/E –Yield –
Universe Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Universe Pharmaceuticals's cash was $29.05M at Mar 31, 2026. For fiscal 2025 it was $33.59M, up 13.9% from the year before. The highest annual figure on record is $5.72B in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $33.59M | +13.9% |
| FY2024 | Sep 30, 2024 | $29.50M | -99.4% |
| FY2023 | Sep 30, 2023 | $5.30B | -7.4% |
| FY2022 | Sep 30, 2022 | $5.72B | +26155.9% |
| FY2021 | Sep 30, 2021 | $21.80M | +116.8% |
| FY2020 | Sep 30, 2020 | $10.06M | +216.6% |
| FY2019 | Sep 30, 2019 | $3.18M | -48.7% |
| FY2018 | Sep 30, 2018 | $6.19M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $29.05M | +155.1% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $33.59M | -99.4% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $47.27M | +80.0% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $29.50M | -99.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $11.39M | -60.2% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $5.30B | +24201.4% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $26.27M | -27.0% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $5.72B | +56814.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $28.58M | +799.5% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $21.80M | +252.2% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $36.00M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $10.06M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $3.18M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $6.19M | – |
See a number that looks wrong?